Suppr超能文献

囊性纤维化患儿肺部疾病严重程度的复杂双基因调控

Complex two-gene modulation of lung disease severity in children with cystic fibrosis.

作者信息

Dorfman Ruslan, Sandford Andrew, Taylor Chelsea, Huang Baisong, Frangolias Daisy, Wang Yongqian, Sang Richard, Pereira Lilian, Sun Lei, Berthiaume Yves, Tsui Lap-Chee, Paré Peter D, Durie Peter, Corey Mary, Zielenski Julian

机构信息

Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

J Clin Invest. 2008 Mar;118(3):1040-9. doi: 10.1172/JCI33754.

Abstract

Although cystic fibrosis (CF) is a monogenic disease, its clinical manifestations are influenced in a complex manner. Severity of lung disease, the main cause of mortality among CF patients, is likely modulated by several genes. The mannose-binding lectin 2 (MBL2) gene encodes an innate immune response protein and has been implicated as a pulmonary modifier in CF. However, reports have been conflicting, and interactions with other modifiers have not been investigated. We therefore evaluated the association of MBL2 with CF pulmonary phenotype in a cohort of 1,019 Canadian pediatric CF patients. MBL2 genotypes were combined into low-, intermediate-, and high-expression groups based on MBL2 levels in plasma. Analysis of age at first infection with Pseudomonas aeruginosa demonstrated that MBL2 deficiency was significantly associated with earlier onset of infection. This MBL2 effect was amplified in patients with high-producing genotypes of transforming growth factor beta 1 (TGFB1). Similarly, MBL2 deficiency was associated with more rapid decline of pulmonary function, most significantly in those carrying the high-producing TGFB1 genotype. These findings provide evidence of gene-gene interaction in the pathogenesis of CF lung disease, whereby high TGF-beta1 production enhances the modulatory effect of MBL2 on the age of first bacterial infection and the rate of decline of pulmonary function.

摘要

尽管囊性纤维化(CF)是一种单基因疾病,但其临床表现受到复杂的影响。肺部疾病是CF患者死亡的主要原因,其严重程度可能受多个基因调控。甘露糖结合凝集素2(MBL2)基因编码一种先天性免疫反应蛋白,并被认为是CF中的一种肺部修饰因子。然而,相关报道存在矛盾,且尚未对其与其他修饰因子的相互作用进行研究。因此,我们在1019名加拿大儿科CF患者队列中评估了MBL2与CF肺部表型的关联。根据血浆中MBL2水平,将MBL2基因型分为低表达、中等表达和高表达组。对首次感染铜绿假单胞菌的年龄分析表明,MBL2缺乏与感染的较早发作显著相关。在转化生长因子β1(TGFB1)高产生基因型的患者中,这种MBL2效应被放大。同样,MBL2缺乏与肺功能的更快下降相关,在携带高产生TGFB1基因型的患者中最为显著。这些发现为CF肺部疾病发病机制中的基因-基因相互作用提供了证据,即高TGF-β1产生增强了MBL2对首次细菌感染年龄和肺功能下降速率的调节作用。

相似文献

10
Gene modifiers in cystic fibrosis.囊性纤维化中的基因修饰因子
J Clin Invest. 2008 Mar;118(3):839-41. doi: 10.1172/JCI35138.

引用本文的文献

3
Modifies Chronic Airway Infection Risk in Cystic Fibrosis.改变囊性纤维化患者慢性气道感染风险。
Ann Am Thorac Soc. 2025 May;22(5):715-723. doi: 10.1513/AnnalsATS.202408-868OC.
7
Subversion of the Complement System by Pseudomonas aeruginosa.铜绿假单胞菌对补体系统的颠覆。
J Bacteriol. 2023 Aug 24;205(8):e0001823. doi: 10.1128/jb.00018-23. Epub 2023 Jul 12.
10
Mucosal Immunity in Cystic Fibrosis.囊性纤维化中的黏膜免疫。
J Immunol. 2021 Dec 15;207(12):2901-2912. doi: 10.4049/jimmunol.2100424.

本文引用的文献

1
Heritability of lung disease severity in cystic fibrosis.囊性纤维化肺病严重程度的遗传力。
Am J Respir Crit Care Med. 2007 May 15;175(10):1036-43. doi: 10.1164/rccm.200608-1164OC. Epub 2007 Mar 1.
3
Gene modifiers of lung disease.肺部疾病的基因修饰因子。
Curr Opin Pulm Med. 2006 Nov;12(6):416-21. doi: 10.1097/01.mcp.0000245707.59138.40.
10
What's new in CF airway inflammation: an update.囊性纤维化气道炎症的新进展:最新情况
Paediatr Respir Rev. 2006;7 Suppl 1:S70-2. doi: 10.1016/j.prrv.2006.04.170. Epub 2006 Jun 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验